Global Rank
Daily Visitors
Last scanned
Domain Age
Updated:
Oncomine Next-Generation Sequencing Solutions for Precision Oncology Research
Oncomine next-generation sequencing NGS and genomic profiling for advancing cancer research and improving cancer patient outcomes in precision oncology.
This website is hosted with HubSpot, Inc., which reserves the following IP addresses for oncomine.com: 199.60.103.31, 199.60.103.225. Moreover, DNS used with this website include ns-1157.awsdns-16.org, ns-1793.awsdns-32.co.uk, ns-35.awsdns-04.com, ns-958.awsdns-55.net. Subnet identifier ranges from 199.60.103.0 to 199.60.103.255. Classless Inter-Domain Routing (CIDR) is 199.60.103.0/24. ARIN net type is Direct Allocation.
Global Rank
Daily Visitors
Last scanned
Domain Age
ns-1157.awsdns-16.org
ns-1793.awsdns-32.co.uk
ns-35.awsdns-04.com
ns-958.awsdns-55.net
{{value}}
2003-05-05
2026-05-05
MarkMonitor Inc.
{{value}}
The registrar of oncomine.com is MarkMonitor Inc. and the name expires on 2026-05-05. According to open source data, you can reach the owner at domainadmin@invitrogen.com but please make sure you have a good reason for unsolicited messages. Their country of residence is United States of America.
N/A
200
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A